louisiana glp-1 pancreatitis law firm Novo Nordisk is suing Eli Lilly over its ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro and Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW ⬇️ Louisiana spent over $1B on

Wellstar's receipt of the SAMHSA grant builds on the system's established infrastructure through the provision of additional educational resources to healthcare clinicians and the community

A once-weekly basal insulin could absolutely reduce treatment burden for some adults with type 2 diabetes and may help with adherence for people who struggle with daily injections

takes three minutes

1: Growing Demand for Weight-Loss Drugs The most direct consequence of the recent developments is the growth in demand for the weight-loss drugs themselves

Publix said its registered dietitian nutritionists use current scientific research, including the USDA Dietary Guidelines for Americans, to compare similar products